Search hospitals > Colorado > Denver
Colorado Blood Cancer Institute
Claim this profileDenver, Colorado 80218
Global Leader in Multiple Myeloma
Global Leader in Cancer
Conducts research for Lymphoma
Conducts research for Acute Myelogenous Leukemia
Conducts research for Acute Myeloid Leukemia
294 reported clinical trials
12 medical researchers
Summary
Colorado Blood Cancer Institute is a medical facility located in Denver, Colorado. This center is recognized for care of Multiple Myeloma, Cancer, Lymphoma, Acute Myelogenous Leukemia, Acute Myeloid Leukemia and other specialties. Colorado Blood Cancer Institute is involved with conducting 294 clinical trials across 448 conditions. There are 12 research doctors associated with this hospital, such as Nicholas DiBella, Alireza Eghtedar, Michael Tees, MD, and Marcello Rotta.Area of expertise
1Multiple Myeloma
Global LeaderStage II
Stage I
FLT3 positive
2Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
103 reported clinical trials
193 drugs studied
Alireza EghtedarColorado Blood Cancer Institute4 years of reported clinical research
Studies Acute Myelogenous Leukemia
Studies Leukemia
12 reported clinical trials
25 drugs studied
Michael Tees, MDColorado Blood Cancer Institute3 years of reported clinical research
Studies Lymphoma
Studies Diffuse Large B-Cell Lymphoma
7 reported clinical trials
10 drugs studied
Marcello RottaColorado Blood Cancer Institute2 years of reported clinical research
Studies Acute Myeloid Leukemia
Studies Acute Myelogenous Leukemia
7 reported clinical trials
23 drugs studied
Clinical Trials running at Colorado Blood Cancer Institute
Multiple Myeloma
Lung Cancer
Non-Hodgkin's Lymphoma
Lymphoma
Breast Cancer
Melanoma
Cancer
Colorectal Cancer
B-Cell Lymphoma
Breast cancer
Teclistamab + Lenalidomide
for Multiple Myeloma
This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclistamab in combination with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy after autologous stem cell transplant.
Recruiting3 awards Phase 35 criteria
Ide-cel + Lenalidomide
for Multiple Myeloma
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
Recruiting2 awards Phase 31 criteria
Anitocabtagene Autoleucel
for Multiple Myeloma
The goal of this study (iMMagine-3) is to compare the study drug, anitocabtagene autoleucel to standard of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, including an anti-CD38 monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in participants with RRMM.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Colorado Blood Cancer Institute?
Colorado Blood Cancer Institute is a medical facility located in Denver, Colorado. This center is recognized for care of Multiple Myeloma, Cancer, Lymphoma, Acute Myelogenous Leukemia, Acute Myeloid Leukemia and other specialties. Colorado Blood Cancer Institute is involved with conducting 294 clinical trials across 448 conditions. There are 12 research doctors associated with this hospital, such as Nicholas DiBella, Alireza Eghtedar, Michael Tees, MD, and Marcello Rotta.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.